William Blair adds Oracle, removes Meta from conviction list

Analyst
โดย Seeking Alpha·Read original
Summary · why it matters

William Blair updated its July Analyst Conviction List, adding Oracle, American Express, Ecolab, Comfort Systems USA, Boot Barn, LifeStance Health, Genmab, Silence Therapeutics, Tyra Biosciences, Arxis, Novanta, Dynatrace, Everpure, and ServiceTitan. The firm said Oracle is emerging as a major beneficiary of the AI infrastructure buildout, with hyperscale cloud commitments driving record remaining performance obligations and stronger revenue visibility. Removed stocks included Meta Platforms, Chewy, SharkNinja, Chime, Flywire, LPL Financial, Palomar, Exponent, GFL Environmental, Encompass Health, Waystar, Insmed, LENZ Therapeutics, Ocular Therapeutix, Curtiss-Wright, Mayville Engineering, Standex, Arista Networks, Guidewire, JLL, Procore, and Rubrik, all through automatic six-month removals. Axsome Therapeutics was removed after FDA approval for Auvelity in Alzheimer’s disease agitation and a roughly 48% gain since its April addition, while Rollins was removed as near-term growth and margin trends looked less clear.

Impact on stocks 55

Artificial Intelligence · 10 stocks
Dynatrace Holdings LLC
DT
▲ PositiveCapitalrelevance

Added to William Blair's Analyst Conviction List, signaling analyst endorsement.

Oracle Corporation
ORCL
▲ PositiveDemandrelevance

William Blair added Oracle to its conviction list, citing hyperscale cloud commitments driving record remaining performance obligations and stronger revenue visibility.

Comfort Systems USA Inc
FIX
± MixedCapitalrelevance

Comfort Systems USA was added to the conviction list, but no specific reason given in the article.

Digital Finance & Tokenization · 6 stocks
American Express Company
AXP
± MixedCapitalrelevance

American Express was added to the conviction list, but no specific reason given in the article.

Industrials · 5 stocks
Rollins Inc
ROL
▼ NegativeCapitalrelevance

Removed from William Blair's conviction list due to less clear near-term growth and margin trends.

Biotech & Genomic Medicine · 5 stocks
Axsome Therapeutics Inc
AXSM
▼ NegativeRegulationrelevance

Axsome was removed after FDA approval for Auvelity, likely a sell-the-news event, but removal is negative for conviction list.

Consumer Discretionary · 5 stocks
Boot Barn Holdings Inc
BOOT
± MixedCapitalrelevance

Boot Barn was added to the conviction list, but no specific reason given in the article.

Health Care · 3 stocks
Climate Adaptation & Water · 3 stocks
Ecolab Inc
ECL
± MixedCapitalrelevance

Ecolab was added to the conviction list, but no specific reason given in the article.

Defense & Geopolitical Fragmentation · 3 stocks
Aging Population · 3 stocks
Energy Transition & Power Demand · 1 stocks
Energy · 1 stocks
Real Estate · 1 stocks
Robotics & Physical AI · 1 stocks
Information Technology · 1 stocks
Semiconductors · 1 stocks

Theme Impact 1

Related news

IREN Fair Value Trimmed to US$79.03 as AI Cloud Wins Meet Build Out Risks

IREN's fair value estimate has been trimmed from US$80.93 to US$79.03, a modest adjustment reflecting a mix of growing AI cloud contracts and ongoing questions around execution and supply build out through 2027. The revision lifts revenue growth assumptions to 168.01% from 125.79% and net profit margin expectations to 11.73% from 5.79%, while the future P/E assumption drops to 31.26x from 90.29x and the discount rate rises to 9.41% from 8.83%. On the bullish side, JPMorgan shifted IREN from Underweight to Overweight with a US$65 price target, citing a partnership with Nvidia, new customer signings and higher industry pricing, while H.C. Wainwright raised its target to US$90 after IREN announced US$2.8b of new multi year AI cloud contracts and lifted its 2026 AI cloud annual recurring revenue target to more than US$4b. Northland initiated IREN at Outperform with a US$99 price target, and Freedom Capital upgraded the stock from Hold to Buy. Freedom Capital nonetheless flagged execution on supply additions over the next two years as a central risk, noting the story depends heavily on adding capacity on schedule.
Simply Wall St·8hRead more →
impact 4

Nvidia-Backed Nscale Files for US IPO After $1.02 Billion Loss

Nscale, the London-based AI data center developer backed by Nvidia and Microsoft, filed publicly for an initial public offering in New York, seeking to raise as much as $3 billion. The company reported a net loss of $1.02 billion on revenue of $140.6 million for the six months ended June 30, compared with a net loss of $368.9 million on revenue of $10.4 million a year earlier, according to its Friday filing with the US Securities and Exchange Commission. Spun off from a cryptocurrency mining operation in early 2024, Nscale was valued at about $14.6 billion in a March Series C round led by Aker ASA and 8090 Industries, with Nvidia and Nokia Oyj also participating. The company has agreed to add more than 30,000 Nvidia chips to an existing rental agreement with Microsoft at its Narvik, Norway gigafactory, and Anthropic has agreed to spend $45 billion to rent AI cloud computing power from its flagship West Virginia data center development. The offering is being led by Goldman Sachs, JPMorgan Chase and Morgan Stanley, with shares expected to trade on the New York Stock Exchange under the symbol NSCL.
Bloomberg·10hRead more →
2impact 4

Goldman Sachs Warns S&P 500 Earnings Growth Set to Cool

Goldman Sachs Group expects the rapid rise in S&P 500 earnings to cool rather than reverse, saying several temporary forces are currently lifting profits. S&P 500 earnings per share rose 51% year over year in the second quarter, with growth over the past four quarters reaching 26%, a pace the firm said has pushed profits above their longer-term trend, though the index's forward price-to-earnings ratio has eased to 19 from 23 a year ago and now matches its 10-year average. Artificial intelligence spending is a major contributor, with Amazon, Meta Platforms, Microsoft and Alphabet expected to spend about $800 billion on capital projects this year, nearly double 2025 levels, and Goldman expects that earnings boost to fade as spending growth slows and depreciation rises. Semiconductor margins and gains from technology companies' investment holdings are also supporting earnings, and Goldman said weaker chip margins could cut S&P 500 earnings by about 10%, while investment gains that helped second-quarter profits are expected to contribute less in 2027.
GuruFocus·10hRead more →